Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Doyle, Yvonne G. (1995)
Publisher: South East Institute of Public Health
Languages: English
Types: Other
Subjects: RC0254, RA0421
Primary lung cancer is the commonest malignant disease in the developed world, and is the\ud most prevalent form of cancer among men over 65 years. It continues to rise in those aged\ud over 75 years. Mortality from lung cancer is increasing in women. The condition still has a\ud short clinical course and a poor prognosis. The literature is in agreement about the effectiveness\ud of preventing lung cancer incidence by targeting smoking behaviour, particularly in preventing\ud young people taking up smoking. There is further consensus about the lack of a population\ud screening method which can be recommended, and the desirability of detecting non-small cell\ud lung cancer early enough for surgical intervention. The effectiveness of treatment for advanced\ud disease is less marked, and it is of concern that many people who present with lung cancer are\ud unsuitable for surgical intervention. The role of palliative care is critical in this condition and\ud this care should be introduced early in the interaction between the patient and the services.\ud
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Sanderson H, Mountney L, Harris 1. Cancer of the Lung. Epidemiologically Based Needs Assessment. London: NHS Management Executive, 1994.
    • 2. Goddard E. Smoking among secondary school children in England in1988. London: HMSO, 1989.
    • 3. Egger G, Fitzgerlad W, Frape G et al. Results of large scale media anti-smoking campaign in Australia. BMJ 1983;287: 1125-8.
    • 4. Wilson DH. Evaluation of the South Australian pilot stop smoking progranuue in Whyalla, Port Augusta and Port Pirie, March 1983. South Australia Health Commission, 1984.
    • 5. Russell MAH, Wilson C, Taylor C, Baker CD. Effect of general practitioners advice against smoking. BMJ 1979;2:231-5.
    • 6. Fisher KJ, Glascow RE, Terborg JR. Work site smoking cessation: a meta-analysis of long term quit rates from controlled studies. J ace Medicine 1990;32:429-39.
    • 7. Windsor RA, Warner KE, Cutter GR. A cost effectiveness analysis of self-help smoking cessation methods for pregnant womeu. Public Health Reports 1988;103:83-8.
    • 8. Mullen PD, Quinn YP, Ershoff DH. Maintenance of non-smoking postpartum by women who stopped smoking during pregnancy. Am J Public Health 1990;80:992-4. 9.Marshall A, Raw M. Nicotene chewing gum in general practice: effect offollow-up appointtnents. BMJ 19R5;290:1397-8. 10.Raw M. The treattnent of cigarette dependence. In: Israel Y, Galser FB, Kalant H, Popham RE, Sclunidt W, Smart RG (eds). Research advances in Alcohol and Drug problems. Yol4 . New York: Plenum Publishing Coorporation, 1978: p 441-85. 12.Preventive Medicine. A report of a working party of the Royal College of Physicians. London: RCP Publications, 1991. 13.Wald NJ, Nanchatal K, Cuckle H. Does breathing other people's smoke cause lung cancer? BMJ 1983; 293: 1217.
    • 14. Association of London Authorities, London Boroughs Association and the South East Institute of Public Health. Air Quality in London 1994. Tunbridge Wells: The South East Institute of Public Health, 1995.
    • 15. Dockery DW et al. An association between air polluation and mortality in six US cities. Nengl J Med 1993;329:1753-9.
    • 16. Souharni R, Tobias J. Cancer and its management. Edinburgh: Blackwell Scientific Publications, 1995. p 227-249. 17.Intemational Agency for Researcb on Cancer. Evaluation of carcinogenic risks to humans. IARC monographs, Suppl 7. Lyon: IARC, 1987.
    • 18. Doll R, Peto R. The causes of cancer. Oxford: Oxford University Press, 1981.
    • 19. Fu H, Boffetta P. Cancer and occupational exposure to inorganic lead compounds: a meta-analyais of published data. Occupational and Environmental Medicine 1995;52:73-81.
    • 35. Pugtach RD. Radiologic evaluation in chest malignancies. A review of imaging modalities. Chest 1995;I07:294S-297S.
    • 53. Marino P, Pampallona S, Preatoni A, Cantoni A, Invemizzi F. Chemotherapy vs supportive care in advance non-small cell lung cancer. Results of a meta-analysis of the literature. Chest 1994;106:861-5.
    • 54. Miller VA, Rigas JR, Grant SC, Pisters KM, Kris MG. New chemotherapeutic agents for non-small cell lung cancer. Chest 1995;107: 306S-31S. 55.Evans WK. Management of metastatic non-small cell lung cancer and a consideration of cost. Chest 1993; 103:68S-71S. 56. Darnstrup L, Poulsen HS. Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer. Lung Cancer 1994; 11: 153-78. 57.Stephem RJ, Girling DJ, Machin D. Treatment related deaths in small cell lung cancer trials: can patients at risk be identified? Medical Research Council Lung Cancer Working Party. Lung Cancer 1994;11 :259-74. 58.Hamen HH, Rorth M. Lung cancer. Cancer chemotherapy and biological response modifiers 1994; 15:484-500. 59. Van Zandwijk N. Are we moving towards continuous treatment in small cell lung cancer'! Anticancer Research 1994;14:309-11. 60.Jett JR. Current treatment of unresectable lung cancer. Mayo Clinic Proceedings 1993;68:603-11. 61. Tiefengraber E, Sebasta C, Keir P, Ruckser R, Habertheuer KH, Hinterberger W. Possible role of autotransplantation in small cell bronchial carcinoma. Wiener Medizinische Wochenschrift 1995;145:50-2. 63. Ihde DC. Small cell lung cancer. State of the art therapy 1994. Chest 1995;107:243S-248S. 64.Abner A. Prophylactic cranial irradiation in the treatment of small cell carcinoma of the Inng. Chest 1993;103:445S-448S. 65.Jackson DV, Case LD. Small cell lung cancer: a 10 year perspective. Seminars in Oncology 1986;13:63-74.
    • 66. Kristjansen PE. Should current management of small cell lung cancer include prophylactic cranial irradiation? Lung Cancer 1994; 10 Suppl I: S319-29.
    • 67. drings P, Fischer JR. Biology and clincial use of GM-CSF in lung cancer. Lung 1990; 168: 1059-68. 68.Evers BM, Parekh D, Townsend CM, Thompson JC. Somatostatin and analogues in the treaunent of cancer. A review. Ann Surg 1991;213: 190-8. 69.Fishbein GE. lmmunotherapy of lung cancer. Seminars in Oncology 1993;20:351-8. 70.Taghaferri F, Sirovicj I. Stipa F, Valente MG, Pupelis G, Tremiterra S. Systemic specific active innnunotherapy for solid tunours. An overview about cancer vaccinetherapy. Recenti Pregressi in Medicina 1994;85:591-6.
    • 72. Duncan W. An evaluation of the results of neutron therapy trials. Acta Oncologica 1994;33:299-306.
    • 73. Spitler LE, Miller L. Clinical trials of transfer factor in malignancy. Journal of Experimental Pathology 1987;3:549-64.
    • 74. Dumon JF, Venuta F, Kovitz KL, Dumon MC. Tracheobronchial stents: a 5 year experience with the Dumon steraard a review of other current stents. In: Lung Cancer. Frontiers in Science and Treaunent. Genoa: Grafica LP, 1994:255-64.
    • 75. Todd TR. Pulmonary metastectomy. Current indications for removing lung metastases. Chest 1993; 103:40 1S-403S. 76.Barr LC, Skene AI, Thomas JM. Metastasectomy. British J Surgery 1992;79:1268-74. 77. MRC Lung Cancer Working Party. Inoperable non-small cell lung cancer. An MRC randomised trial of palliative radiotherapy with two fractions or ten fractions. Br J Oncology 1991;63 :265-70. 78.Rubens RD, Towlson KE, Ramirez Al, Coltart S, Slevin ML, Terrell C, Tirnofby AR. Appropriate chemofberapy for palliating advanced cancer. BMJ 1992;304:35-40. 79.Adelstein DJ. Palliative chemofberapy for non-small cell lung cancer, Seminars in Oncology 1995;22:35-9. 80.Loehrer PJ. Palliative therapy: extensive small cell lung cancer. Seminars in Oncology 1995;22:40-4. 81.Department of Health and the Welsh Office. A Policy Framework for Commissioning Cancer Services. A report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales. London; Department of Health, 1995. 82.Standing Medical Advisory Committee/Standing Nursing Advisory Committee. The principles and provision of palliative care. London: Department of Health, 1992.
  • No related research data.
  • No similar publications.

Share - Bookmark

Download from

Cite this article